Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,123 | 29,429 | 18,583 | 28,401 | 25,293 |
| Marketable Securities | 224,264 | 275,523 | 304,888 | 328,416 | 355,175 |
| Receivables | 1,314 | 347 | 189 | 97 | 243 |
| TOTAL | $289,597 | $317,693 | $334,599 | $367,979 | $390,699 |
| Non-Current Assets | |||||
| PPE Net | 3,995 | 3,747 | 3,753 | 3,744 | 3,484 |
| Intangibles | 27,190 | 27,190 | 27,190 | 27,190 | 27,190 |
| Other Non-Current Assets | 3,737 | 4,105 | 3,684 | 4,048 | 2,668 |
| TOTAL | $34,922 | $35,042 | $34,627 | $34,982 | $33,342 |
| Total Assets | $324,519 | $352,735 | $369,226 | $402,961 | $424,041 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,374 | 3,340 | 2,272 | 15,902 | 1,019 |
| Accrued Expenses | 9,374 | 12,835 | 11,425 | 11,229 | 9,234 |
| Other current liabilities | 978 | 990 | 1,152 | 1,393 | 2,505 |
| TOTAL | $15,219 | $18,610 | $16,287 | $29,949 | $14,560 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,560 | 7,921 | 7,523 | 7,919 | 11,380 |
| TOTAL | $6,560 | $7,921 | $7,523 | $7,919 | $11,380 |
| Total Liabilities | $21,779 | $26,531 | $23,810 | $37,868 | $25,940 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,252 | 47,207 | 47,100 | 46,772 | 46,754 |
| Common Shares | 47 | 47 | 47 | 47 | 47 |
| Retained earnings | -1,285,293 | -1,255,932 | -1,229,445 | -1,202,661 | -1,166,657 |
| Other shareholders' equity | 2,123 | 1,260 | -112 | -417 | 112 |
| TOTAL | $302,740 | $326,204 | $345,416 | $365,093 | $398,101 |
| Total Liabilities And Equity | $324,519 | $352,735 | $369,226 | $402,961 | $424,041 |